Patent Assignment
Reel/Frame 019960/0897
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded: 2007-10-12
Received: 2007-10-12
Pages: 4
Assignor
CTL IMMUNO THERAPIES, CORP.
Executed: 2002-12-16
Assignee
MANNKIND CORPORATION
28903 NORTH AVENUE PAINE, VALENCIA, CA, 91355, UNITED STATES
Covered Applications
(11)
Anti-Neovasculature Preparations for Cancer
App. No. 11/772,811
→
EPITOPE SYNCHRONIZATION IN ANTIGEN PRESENTING CELLS
App. No. 11/683,397
→
Avoidance of undesirable replication intermediates in plasmid propagation
App. No. 11/418,450
→
METHOD OF INDUCING A CTL RESPONSE
App. No. 11/313,152
→
Anti-neovasculature preparations for cancer
App. No. 11/073,347
→
Method of epitope discovery
App. No. 10/956,401
→
EXPRESSION VECTORS ENCODING EPITOPES OF TARGET-ASSOCIATED ANTIGENS AND METHODS FOR THEIR DESIGN
App. No. 10/837,217
→
EXPRESSION VECTORS ENCODING EPITOPES OF TARGET-ASSOCIATED ANTIGENS AND METHODS FOR THEIR DESIGN
App. No. 10/777,053
→
AVOIDANCE OF UNDESIRABLE REPLICATION INTERMEDIATES IN PLASMID PROPAGATION
App. No. 10/437,830
→
ANTI-NEOVASCULATURE PREPARATIONS FOR CANCER
App. No. 10/094,699
→
Epitope synchronization in antigen presenting cells
App. No. 10/026,066
→